Kostas Biliouris
Stock Analyst at BMO Capital
(0)
# 4573
Out of 5,231 analysts
51
Total ratings
23.81%
Success rate
-14.95%
Average return
Main Sectors:
Top Industries:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
Intellia Therapeutic... | Maintains: Outperform | 70 50 | 10.15 | 392.61% | 6 | Jan 10, 2025 | |
Precision BioScience... | Upgrades: Outperform | 34 34 | 4.97 | 584.1% | 3 | Jan 10, 2025 | |
Centessa Pharmaceuti... | Maintains: Outperform | 20 35 | 16.95 | 106.49% | 6 | Sep 16, 2024 | |
Metagenomi | Maintains: Outperform | 22 17 | 2.64 | 543.94% | 2 | Aug 15, 2024 | |
Ionis Pharmaceutical... | Downgrades: Market Perform | 67 60 | 32.85 | 82.65% | 1 | Aug 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 63 40 | 5.01 | 698.4% | 4 | Jul 18, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 90 90 | 36.03 | 149.79% | 3 | Jul 3, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 234 234 | 274.02 | -14.6% | 4 | Jun 24, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 170 200 | 115.53 | 73.12% | 4 | Jun 24, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 120 120 | 33.16 | 261.88% | 3 | May 15, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 57 | 25.95 | 119.65% | 3 | Mar 27, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | 37 | 36.42 | 1.59% | 1 | Jan 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 67 | 5.22 | 1183.52% | 1 | Jan 31, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 102 100 | 63.48 | 57.53% | 4 | Nov 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 19 | 2.76 | 588.41% | 1 | Oct 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 98 49 | n/a | n/a | 2 | Jan 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 48 62 | 7.7 | 705.19% | 2 | Jul 18, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 98 | 41.25 | 137.58% | 1 | Jun 17, 2022 |